RMAM
ENZN

Raab & Moskowitz Asset Management’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Raab & Moskowitz Asset Management’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-250
Closed – – 463
2014
Q4 		$0 Buy
+250
New +$262 ﹤0.01% 502

Other funds holding ENZN

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Raab & Moskowitz Asset Management's ENZN Position: Q1 2015 in Review

Raab & Moskowitz Asset Management sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q1 2015, closing a stake of 250 shares.

Raab & Moskowitz Asset Management first reported a position in ENZN in Q4 2014 and held it in 1 quarter. The position peaked at $0 in Q4 2014. 53 funds tracked by Wall St. Rank hold ENZN as of Q1 2015.

  • Raab & Moskowitz Asset Management reported no remaining ENZON PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Raab & Moskowitz Asset Management sold 250 ENZON PHARMACEUTICALS INC shares in Q1 2015.
  • Raab & Moskowitz Asset Management first reported a position in ENZON PHARMACEUTICALS INC in Q4 2014 and held it in 1 quarter.
  • Raab & Moskowitz Asset Management's ENZON PHARMACEUTICALS INC position peaked at $0 in Q4 2014.
  • 53 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q1 2015.

Based on Raab & Moskowitz Asset Management's 13F filing for Q1 2015, filed 12 May 2015.